Cristin-person-ID: 428575
Person

Berit Gravdehaug

  • Stilling:
    Universitetslektor
    ved Klinikk for kirurgiske fag ved Universitetet i Oslo
  • Stilling:
    Overlege
    ved Kirurgisk divisjon ved Akershus universitetssykehus HF

Resultater Resultater

“It was an important part of my treatment”: a qualitative study of Norwegian breast Cancer patients’ experiences with mainstreamed genetic testing.

Strømsvik, Nina; Olsson, Pernilla Marie A.; Gravdehaug, Berit; Lurås, Hilde; Schlichting, Ellen; Jørgensen, Kjersti; Wangensteen, Teresia; Vamre, Tone; Heramb, Cecilie; Mæhle, Lovise Olaug mfl.. 2022, Hereditary Cancer in Clinical Practice. UIT, UIO, AHUS, OUS, INNLANDET, HVLVitenskapelig artikkel

Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.

Bahrami, Nazli; Jabeen, Shakila; Tahiri, Andliena; Sauer, Torill; Ødegård, Hilde Presterud; Geisler, Stephanie Beate; Gravdehaug, Berit; Reitsma, Laurens Cornelus; Selsås, Knut; Kristensen, Vessela N. mfl.. 2021, Breast Cancer Research and Treatment. UIO, AHUS, OUSVitenskapelig artikkel

Eighth International Symposium on hereditary breast and ovarian cancer. Familial Cancer.

Strømsvik, Nina; Olsson, Pernilla Marie A.; Gravdehaug, Berit; Mæhle, Lovise; Schlichting, Ellen; Lurås, Hilde; Jørgensen, Kjersti; Wangensteen, Urd Teresia; Vamre, Tone Bøe Aaman; Heramb, Cecilie mfl.. 2021, Familial Cancer. UNN, UIO, AHUS, OUS, INNLANDET, HVLSammendrag/abstract

Breast Cancer Patients' Experiences with Mainstreamed Genetic Testing in Two Hospitals in South Eastern Norway - Preliminary results.

Strømsvik, Nina; Olsson, Pernilla Marie A.; Gravdehaug, Berit; Mæhle, Lovise Olaug; Lurås, Hilde; Schlichting, Ellen; Jørgensen, Kjersti; Wangensteen, Urd Teresia; Vamre, Tone; Grindedal, Eli Marie mfl.. 2021, BRCA 2021: A Vision of the Future – The Eighth International Symposium on Hereditary Breast and Ovarian Cancer. UNN, UIO, AHUS, OUS, INNLANDET, HVLPoster

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): Extended follow-up of a 2×2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Heck, Siri Lagethon; Mecinaj, Albulena; Ree, Anne Hansen; Hoffmann, Pavel; Schulz-Menger, Jeanette; Fagerland, Morten; Gravdehaug, Berit; Røsjø, Helge; Steine, Kjetil; Geisler, Jürgen mfl.. 2021, Circulation. HELIOS, UIO, AHUS, OUS, CHARITEVitenskapelig artikkel
1 - 5 av 25 | Neste | Siste »